Advertisement
American Journal of Kidney Diseases

Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients

Published:September 29, 2016DOI:https://doi.org/10.1053/j.ajkd.2016.07.031
      Maintenance dialysis patients experience a high burden of physical and emotional symptoms that directly affect their quality of life and health care utilization. In this review, we specifically highlight common troublesome symptoms affecting dialysis patients: insomnia, restless legs syndrome, and uremic pruritus. Epidemiology, pathophysiology, and evidence-based current treatment are reviewed with the goal of providing a guide for diagnosis and treatment. Finally, we identify multiple additional areas of further study needed to improve symptom management in dialysis patients.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abdel-Kader K.
        • Unruh M.L.
        • Weisbord S.D.
        Symptom burden, depression, and quality of life in chronic and end-stage kidney disease.
        Clin J Am Soc Nephrol. 2009; 4: 1057-1064
        • Murtagh F.E.
        • Addington-Hall J.
        • Higginson I.J.
        The prevalence of symptoms in end-stage renal disease: a systematic review.
        Adv Chronic Kidney Dis. 2007; 14: 82-99
        • Davison S.N.
        • Jhangri G.S.
        Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients.
        J Pain Symptom Manage. 2010; 39: 477-485
        • Lowney A.C.
        • Myles H.T.
        • Bristowe K.
        • et al.
        Understanding what influences the health-related quality of life of hemodialysis patients: a collaborative study in England and Ireland.
        J. Pain Symptom Manage. 2015; 50: 778-785
        • Claxton R.N.
        • Blackhall L.
        • Weisbord S.D.
        • Holley J.L.
        Undertreatment of symptoms in patients on maintenance hemodialysis.
        J. Pain Symptom Manage. 2010; 39: 211-218
        • Weisbord S.D.
        • Fried L.F.
        • Mor M.K.
        • et al.
        Renal provider recognition of symptoms in patients on maintenance hemodialysis.
        Clin J Am Soc Nephrol. 2007; 2: 960-967
        • Davison S.N.
        • Levin A.
        • Moss A.H.
        • et al.
        Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.
        Kidney Int. 2015; 88: 447-459
        • Elder S.J.
        • Pisoni R.L.
        • Akizawa T.
        • et al.
        Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Nephrol Dial Transplant. 2008; 23: 998-1004
        • Lindner A.V.
        • Novak M.
        • Bohra M.
        • Mucsi I.
        Insomnia in patients with chronic kidney disease.
        Semin Nephrol. 2015; 35: 359-372
        • Sateia M.J.
        International Classification of Sleep Disorders-Third Edition: highlights and modifications.
        Chest. 2014; 146: 1387-1394
        • Levenson J.C.
        • Kay D.B.
        • Buysse D.J.
        The pathophysiology of insomnia.
        Chest. 2015; 147: 1179-1192
        • Koch B.C.
        • Nagtegaal J.E.
        • Kerkhof G.A.
        • ter Wee P.M.
        Circadian sleep-wake rhythm disturbances in end-stage renal disease.
        Nat Rev Nephrol. 2009; 5: 407-416
        • Iliescu E.A.
        • Yeates K.E.
        • Holland D.C.
        Quality of sleep in patients with chronic kidney disease.
        Nephrol Dial Transplant. 2004; 19: 95-99
        • Unruh M.
        • Kurella Tamura M.
        • Larive B.
        • et al.
        Impact of sleep quality on cardiovascular outcomes in hemodialysis patients: results from the Frequent Hemodialysis Network Study.
        Am J Nephrol. 2011; 33: 398-406
        • Koch B.C.
        • Nagtegaal J.E.
        • Hagen E.C.
        • et al.
        Subjective sleep efficiency of hemodialysis patients.
        Clin Nephrol. 2008; 70: 411-416
        • Holley J.L.
        • Nespor S.
        • Rault R.
        A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis.
        Am J Kidney Dis. 1992; 19: 156-161
        • Parker K.P.
        • Bliwise D.L.
        • Rye D.B.
        Hemodialysis disrupts basic sleep regulatory mechanisms: building hypotheses.
        Nurs Res. 2000; 49: 327-332
        • Hou Y.
        • Hu P.
        • Liang Y.
        • Mo Z.
        Effects of cognitive behavioral therapy on insomnia of maintenance hemodialysis patients.
        Cell Biochem Biophys. 2014; 69: 531-537
        • Winkelman J.W.
        Clinical practice. Insomnia disorder.
        N Engl J Med. 2015; 373: 1437-1444
        • Zachariae R.
        • Lyby M.S.
        • Ritterband L.M.
        • O'Toole M.S.
        Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - a systematic review and meta-analysis of randomized controlled trials.
        Sleep Med Rev. 2015; 30: 1-10
        • Sabbatini M.
        • Crispo A.
        • Pisani A.
        • et al.
        Zaleplon improves sleep quality in maintenance hemodialysis patients.
        Nephron Clin Pract. 2003; 94: c99-c103
        • Russcher M.
        • Koch B.C.
        • Nagtegaal J.E.
        • et al.
        Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial.
        Br J Clin Pharmacol. 2013; 76: 668-679
        • Jaber B.L.
        • Schiller B.
        • Burkart J.M.
        • et al.
        Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances.
        Clin J Am Soc Nephrol. 2011; 6: 1049-1056
        • Unruh M.L.
        • Larive B.
        • Eggers P.W.
        • et al.
        The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.
        Nephrol Dial Transplant. 2016; 31: 984-991
        • Hanly P.J.
        • Gabor J.Y.
        • Chan C.
        • Pierratos A.
        Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis.
        Am J Kidney Dis. 2003; 41: 403-410
        • Toth-Manikowski S.M.
        • Sozio S.M.
        Cooling dialysate during in-center hemodialysis: beneficial and deleterious effects.
        World J Nephrol. 2016; 5: 166-171
        • Novak M.
        • Winkelman J.W.
        • Unruh M.
        Restless legs syndrome in patients with chronic kidney disease.
        Semin Nephrol. 2015; 35: 347-358
        • Venkateshiah S.B.
        • Ioachimescu O.C.
        Restless legs syndrome.
        Crit Care Clin. 2015; 31: 459-472
        • Winkelman J.W.
        • Chertow G.M.
        • Lazarus J.M.
        Restless legs syndrome in end-stage renal disease.
        Am J Kidney Dis. 1996; 28: 372-378
        • Unruh M.L.
        • Levey A.S.
        • D'Ambrosio C.
        • Fink N.E.
        • Powe N.R.
        • Meyer K.B.
        Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival.
        Am J Kidney Dis. 2004; 43: 900-909
        • Tekdos Demircioglu D.
        • Kavadar G.
        • Esen Ore O.
        • Emre T.Y.
        • Yaka U.
        Relationship between restless leg syndrome and quality of life in uremic patients.
        Agri. 2015; 27: 73-78
        • La Manna G.
        • Pizza F.
        • Persici E.
        • et al.
        Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment.
        Nephrol Dial Transplant. 2011; 26: 1976-1983
        • Dikici S.
        • Bahadir A.
        • Baltaci D.
        • et al.
        Association of anxiety, sleepiness, and sexual dysfunction with restless legs syndrome in hemodialysis patients.
        Hemodial Int. 2014; 18: 809-818
        • Kutner N.G.
        • Zhang R.
        • Bliwise D.L.
        Restless legs syndrome is underdiagnosed in the US Renal Data System.
        QJM. 2013; 106: 487
        • Schormair B.
        • Plag J.
        • Kaffe M.
        • et al.
        MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease.
        J Med Genet. 2011; 48: 462-466
        • Molnar M.Z.
        • Novak M.
        • Ambrus C.
        • et al.
        Restless legs syndrome in patients after renal transplantation.
        Am J Kidney Dis. 2005; 45: 388-396
        • Roger S.D.
        • Harris D.C.
        • Stewart J.H.
        Possible relation between restless legs and anaemia in renal dialysis patients.
        Lancet. 1991; 337: 1551
        • Hening W.A.
        • Buchfuhrer M.J.
        • Lee H.B.
        Clinical Management of Restless Legs Syndrome.
        Professional Communications, Inc, West Islip, NY2007
        • de Oliveira M.M.
        • Conti C.F.
        • Valbuza J.S.
        • de Carvalho L.B.
        • do Prado G.F.
        The pharmacological treatment for uremic restless legs syndrome: evidence-based review.
        Mov Disord. 2010; 25: 1335-1342
        • Walker S.L.
        • Fine A.
        • Kryger M.H.
        l-DOPA/carbidopa for nocturnal movement disorders in uremia.
        Sleep. 1996; 19: 214-218
        • Trenkwalder C.
        • Stiasny K.
        • Pollmacher T.
        • et al.
        l-Dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
        Sleep. 1995; 18: 681-688
        • Molnar M.Z.
        • Novak M.
        • Mucsi I.
        Management of restless legs syndrome in patients on dialysis.
        Drugs. 2006; 66: 607-624
        • Garcia-Borreguero D.
        • Benitez A.
        • Kohnen R.
        • Allen R.
        Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.
        Postgrad Med. 2015; 127: 716-725
        • Pellecchia M.T.
        • Vitale C.
        • Sabatini M.
        • et al.
        Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release.
        Clin Neuropharmacol. 2004; 27: 178-181
        • Giannaki C.D.
        • Sakkas G.K.
        • Karatzaferi C.
        • et al.
        Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study.
        BMC Nephrol. 2013; 14: 194
        • Miranda M.
        • Kagi M.
        • Fabres L.
        • et al.
        Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis.
        Neurology. 2004; 62: 831-832
        • Dauvilliers Y.
        • Benes H.
        • Partinen M.
        • et al.
        Rotigotine in hemodialysis-associated restless legs syndrome: a randomized controlled trial.
        Am J Kidney Dis. 2016; 68: 434-443
        • Thorp M.L.
        • Morris C.D.
        • Bagby S.P.
        A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients.
        Am J Kidney Dis. 2001; 38: 104-108
        • Micozkadioglu H.
        • Ozdemir F.N.
        • Kut A.
        • Sezer S.
        • Saatci U.
        • Haberal M.
        Gabapentin versus levodopa for the treatment of restless legs syndrome in hemodialysis patients: an open-label study.
        Ren Fail. 2004; 26: 393-397
        • Razazian N.
        • Azimi H.
        • Heidarnejadian J.
        • Afshari D.
        • Ghadami M.R.
        Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
        Saudi J Kidney Dis Transpl. 2015; 26: 271-278
        • Sloand J.A.
        • Shelly M.A.
        • Feigin A.
        • Bernstein P.
        • Monk R.D.
        A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.
        Am J Kidney Dis. 2004; 43: 663-670
        • Giannaki C.D.
        • Hadjigeorgiou G.M.
        • Karatzaferi C.
        • et al.
        A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome.
        Nephrol Dial Transplant. 2013; 28: 2834-2840
        • Giannaki C.D.
        • Sakkas G.K.
        • Hadjigeorgiou G.M.
        • et al.
        Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome.
        ASAIO J. 2010; 56: 538-542
        • Mortazavi M.
        • Vahdatpour B.
        • Ghasempour A.
        • et al.
        Aerobic exercise improves signs of restless leg syndrome in end stage renal disease patients suffering chronic hemodialysis.
        Sci World J. 2013; 2013: 628142
        • Sakkas G.K.
        • Hadjigeorgiou G.M.
        • Karatzaferi C.
        • et al.
        Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study.
        ASAIO J. 2008; 54: 185-190
        • Giannaki C.D.
        • Sakkas G.K.
        • Karatzaferi C.
        • et al.
        Combination of exercise training and dopamine agonists in patients with RLS on dialysis: a randomized, double-blind placebo-controlled study.
        ASAIO J. 2015; 61: 738-741
        • Pisoni R.L.
        • Wikstrom B.
        • Elder S.J.
        • et al.
        Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Nephrol Dial Transplant. 2006; 21: 3495-3505
        • Kimata N.
        • Fuller D.S.
        • Saito A.
        • et al.
        Pruritus in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS).
        Hemodial Int. 2014; 18: 657-667
        • Welter Ede Q.
        • Frainer R.H.
        • Maldotti A.
        • Losekann A.
        • Weber M.B.
        Evaluating the association between alterations in mineral metabolism and pruritus in hemodialysis patients.
        Anais Bras Dermatol. 2011; 86: 31-36
        • Stahle-Backdahl M.
        • Hagermark O.
        • Lins L.E.
        Pruritus in patients on maintenance hemodialysis.
        Acta Med Scand. 1988; 224: 55-60
        • Razeghi E.
        • Tavakolizadeh S.
        • Ahmadi F.
        Inflammation and pruritus in hemodialysis patients.
        Saudi J Kidney Dis Transpl. 2008; 19: 62-66
        • Lopes G.B.
        • Nogueira F.C.
        • de Souza M.R.
        • et al.
        Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form.
        Qual Life Res. 2012; 21: 603-612
        • Chiu Y.L.
        • Chen H.Y.
        • Chuang Y.F.
        • et al.
        Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients.
        Nephrol Dial Transplant. 2008; 23: 3685-3689
        • Narita I.
        • Alchi B.
        • Omori K.
        • et al.
        Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients.
        Kidney Int. 2006; 69: 1626-1632
        • Ko M.J.
        • Wu H.Y.
        • Chen H.Y.
        • et al.
        Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study.
        PloS One. 2013; 8: e71404
        • Duque M.I.
        • Thevarajah S.
        • Chan Y.H.
        • Tuttle A.B.
        • Freedman B.I.
        • Yosipovitch G.
        Uremic pruritus is associated with higher Kt/V and serum calcium concentration.
        Clin Nephrol. 2006; 66: 184-191
        • Virga G.
        • Visentin I.
        • La Milia V.
        • Bonadonna A.
        Inflammation and pruritus in haemodialysis patients.
        Nephrol Dial Transplant. 2002; 17: 2164-2169
        • Yamamoto Y.
        • Hayashino Y.
        • Yamazaki S.
        • et al.
        Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan Dialysis Outcomes and Practice Patterns Study.
        Br J Dermatol. 2009; 161: 384-389
        • Tessari G.
        • Dalle Vedove C.
        • Loschiavo C.
        • et al.
        The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study.
        J Nephrol. 2009; 22: 241-248
        • Mathur V.S.
        • Lindberg J.
        • Germain M.
        • et al.
        A longitudinal study of uremic pruritus in hemodialysis patients.
        Clin J Am Soc Nephrol. 2010; 5: 1410-1419
        • Mettang T.
        • Kremer A.E.
        Uremic pruritus.
        Kidney Int. 2015; 87: 685-691
        • Combs S.A.
        • Teixeira J.P.
        • Germain M.J.
        Pruritus in kidney disease.
        Semin Nephrol. 2015; 35: 383-391
        • Morton C.A.
        • Lafferty M.
        • Hau C.
        • Henderson I.
        • Jones M.
        • Lowe J.G.
        Pruritus and skin hydration during dialysis.
        Nephrol Dial Transplant. 1996; 11: 2031-2036
        • Karadag E.
        • Kilic S.P.
        • Karatay G.
        • Metin O.
        Effect of baby oil on pruritus, sleep quality, and quality of life in hemodialysis patients: pretest-post-test model with control groups.
        Jpn J Nurs Sci. 2014; 11: 180-189
        • Lin T.C.
        • Lai Y.H.
        • Guo S.E.
        • et al.
        Baby oil therapy for uremic pruritus in haemodialysis patients.
        J Clin Nurs. 2012; 21: 139-148
        • Breneman D.L.
        • Cardone J.S.
        • Blumsack R.F.
        • Lather R.M.
        • Searle E.A.
        • Pollack V.E.
        Topical capsaicin for treatment of hemodialysis-related pruritus.
        J Am Acad Dermatol. 1992; 26: 91-94
        • Makhlough A.
        • Ala S.
        • Haj-Heydari Z.
        • Kashi Z.
        • Bari A.
        Topical capsaicin therapy for uremic pruritus in patients on hemodialysis.
        Iran J Kidney Dis. 2010; 4: 137-140
        • Tarng D.C.
        • Cho Y.L.
        • Liu H.N.
        • Huang T.P.
        Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream.
        Nephron. 1996; 72: 617-622
        • Gunal A.I.
        • Ozalp G.
        • Yoldas T.K.
        • Gunal S.Y.
        • Kirciman E.
        • Celiker H.
        Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial.
        Nephrol Dial Transplant. 2004; 19: 3137-3139
        • Naini A.E.
        • Harandi A.A.
        • Khanbabapour S.
        • Shahidi S.
        • Seirafiyan S.
        • Mohseni M.
        Gabapentin: a promising drug for the treatment of uremic pruritus.
        Saudi J Kidney Dis Transpl. 2007; 18: 378-381
        • Razeghi E.
        • Eskandari D.
        • Ganji M.R.
        • Meysamie A.P.
        • Togha M.
        • Khashayar P.
        Gabapentin and uremic pruritus in hemodialysis patients.
        Ren Fail. 2009; 31: 85-90
        • Lau T.
        • Leung S.
        • Lau W.
        Gabapentin for uremic pruritus in hemodialysis patients: a qualitative systematic review.
        Can J Kidney Health Dis. 2016; 3: 1-14
        • Aperis G.
        • Paliouras C.
        • Zervos A.
        • Arvanitis A.
        • Alivanis P.
        The use of pregabalin in the treatment of uraemic pruritus in haemodialysis patients.
        J Renal Care. 2010; 36: 180-185
        • Solak Y.
        • Biyik Z.
        • Atalay H.
        • et al.
        Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
        Nephrology (Carlton). 2012; 17: 710-717
        • Papoiu A.D.
        • Emerson N.M.
        • Patel T.S.
        • et al.
        Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease.
        J Neurophysiol. 2014; 112: 1729-1738
        • Peer G.
        • Kivity S.
        • Agami O.
        • et al.
        Randomised crossover trial of naltrexone in uraemic pruritus.
        Lancet. 1996; 348: 1552-1554
        • Pauli-Magnus C.
        • Mikus G.
        • Alscher D.M.
        • et al.
        Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.
        J Am Soc Nephrol. 2000; 11: 514-519
        • Kumagai H.
        • Ebata T.
        • Takamori K.
        • et al.
        Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients.
        Am J Nephrol. 2012; 36: 175-183
        • Yoshimoto-Furuie K.
        • Yoshimoto K.
        • Tanaka T.
        • et al.
        Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients.
        Nephron. 1999; 81: 151-159
        • Shakiba M.
        • Sanadgol H.
        • Azmoude H.R.
        • Mashhadi M.A.
        • Sharifi H.
        Effect of sertraline on uremic pruritus improvement in ESRD patients.
        Int J Nephrol. 2012; 2012: 363901
        • Pour-Reza-Gholi F.
        • Nasrollahi A.
        • Firouzan A.
        • Nasli Esfahani E.
        • Farrokhi F.
        Low-dose doxepin for treatment of pruritus in patients on hemodialysis.
        Iran J Kidney Dis. 2007; 1: 34-37
        • Gilchrest B.A.
        Ultraviolet phototherapy of uremic pruritus.
        Int J Dermatol. 1979; 18: 741-748
        • Gilchrest B.A.
        • Rowe J.W.
        • Brown R.S.
        • Steinman T.I.
        • Arndt K.A.
        Relief of uremic pruritus with ultraviolet phototherapy.
        N Engl J Med. 1977; 297: 136-138
        • Gilchrest B.A.
        • Rowe J.W.
        • Brown R.S.
        • Steinman T.I.
        • Arndt K.A.
        Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action.
        Ann Intern Med. 1979; 91: 17-21
        • Tan J.K.
        • Haberman H.F.
        • Coldman A.J.
        Identifying effective treatments for uremic pruritus.
        J Am Acad Dermatol. 1991; 25: 811-818
        • Ko M.J.
        • Yang J.Y.
        • Wu H.Y.
        • et al.
        Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial.
        Br J Dermatol. 2011; 165: 633-639
        • Kim K.H.
        • Lee M.S.
        • Choi S.M.
        Acupuncture for treating uremic pruritus in patients with end-stage renal disease: a systematic review.
        J Pain Symptom Manage. 2010; 40: 117-125
        • Davison S.N.
        • Jhangri G.S.
        • Johnson J.A.
        Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden.
        Kidney Int. 2006; 69: 1621-1625
        • Davison S.N.
        • Jhangri G.S.
        • Johnson J.A.
        Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients.
        Nephrol Dial Transplant. 2006; 21: 3189-3195
        • Murphy E.L.
        • Murtagh F.E.
        • Carey I.
        • Sheerin N.S.
        Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool.
        Nephron Clin Pract. 2009; 111: c74-c80
        • Weisbord S.D.
        • Fried L.F.
        • Arnold R.M.
        • et al.
        Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index.
        J. Pain Symptom Manage. 2004; 27: 226-240